Salute e Benessere

Mithra releases invitation to its extraordinary securities holders' meeting

Mithra releases invitation to its extraordinary securities holders' meetingLiege, Belgium, 06 November 2023 – 17:45 CET– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health announces today that it has published and issued an invitation to its announced 1and conditionally planned for extraordinary securities holders' meeting that will be held onThursday, 23 November 2023,at 2:00 PM (CET). The notice for the extraordinary general meeting (EGM),...
Nasdaq GlobeNewswire
06/11/2023

Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating…

Lupus is a complex disease with diverse manifestation, limited treatment options and inequitable impact on the affected population. This makes research into patient experience, treatment patterns and long-term clinical outcomes particularly challenging. The registry will enable patients to securely and safely submit their health and symptom data, helping them to better manage their condition, and the de-identified data helps researchers design and drive new clinical studies to improve disease…
PR Newswire
06/11/2023

Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to…

Therapy to be supported by newly awarded $1M grant from Michael J. Fox Foundation Nature Medicineusing investigational ONWARD ARC Therapy to address gait challenges related to Parkinson's disease.The study participant described in theNature Medicinepublication has been living with Parkinson's disease for nearly three decades. He has a severe gait disorder that has not responded to conventional therapies. "I could hardly walk without frequent falls, several times a day...
Nasdaq GlobeNewswire
06/11/2023

Dysphagia Supplement Market to reach $2.3 Billion, Globally, by 2032 at 4.7%…

Request Sample of the Report on Dysphagia Supplement Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/109636 Request Sample of the Report on Dysphagia Supplement Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/109636 Prime determinants of growth Increase in the prevalence of dysphagia and rise in awareness about dysphagia drive the growth of the dysphagia supplement market. However, availability of alternative treatment options...
PR Newswire
06/11/2023

Ipsen - Monthly information relative to the total number of voting rights and…

Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1)31 October 202383,814,526Gross total* of...
Nasdaq GlobeNewswire
06/11/2023

Hemostats Market size worth $ 3.77 Billion, Globally, by 2028 at 5.81% CAGR…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=11749 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=11749 Browse in-depth TOCon" Hemostats Market " 202 - Pages 126 – Tables 37 – Figures Revolutionizing Surgical Practices: Global Hemostats Market Report Unveils Cutting-Edge Innovations and Key Market Insights The global healthcare landscape is undergoing a paradigm shift, thanks to...
PR Newswire
06/11/2023

Bathroom Products Market Size to Grow USD 164710 Million by 2029 at a CAGR of…

Major Factors Driving the Growth of Bathroom Products Market: Major Factors Driving the Growth of Bathroom Products Market : Expanding disposable income, the hotel sector is booming, and smart homes are becoming more popular. Global market expansion is being supported by a variety of macroeconomic variables, including changing demographics, fast urbanization, an increase in nuclear families, an increasing number of couples purchasing new homes, and government intervention through cheap home...
PR Newswire
06/11/2023

ICP MS System Market to Cross USD 599.4 million by 2031, Garnering a 4.6% CAGR…

The mining industry continues to rely on ICP MS for geochemical exploration, ore grade analysis, and mineral resource characterization. The demand for ICP MS systems increases as exploration efforts expand. The mining industry continues to rely on ICP MS for geochemical exploration, ore grade analysis, and mineral resource characterization. The demand for ICP MS systems increases as exploration efforts expand. The development of miniaturized and portable ICP MS systems is opening up new...
PR Newswire
06/11/2023

Surface Disinfectant Market Worth $4.2 Billion | MarketsandMarkets

Browse in-depth TOC on "Surface Disinfectant Market"173 - Tables39 - Figures219 - Pages Browse in-depth TOC on "Surface Disinfectant Market" 173 - Tables 39 - Figures 219 - Pages Surface Disinfectant Market Scope: The alcohol segment accounted for the largest share of the surface disinfectant market, by composition segment, in 2022 Based on composition, the surface disinfectants market is segmented into alcohol, chlorine compounds, quaternary ammonium compounds,...
PR Newswire
06/11/2023

Evaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion…

EVX-01 is Evaxion's lead clinical asset based upon its AI-Immunology™ platform and has recently published a phase 2 clinical update confirming former phase 1 results Principal investigator Professor Adnan Khattak will walk us through this study's encouraging results and explain its potential for revolutionizing cancer treatmentCOPENHAGEN, Denmark, Nov.06, 2023(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company...
Nasdaq GlobeNewswire
06/11/2023

T-cell Therapy Market Size to Grow USD US$ 76.6 billion from 2023-2033 | Says…

Advancements in gene editing technologies, like CRISPR Cas9, can improve the precision and efficiency of modifying T cells, potentially leading to safer and more effective therapies. Allogeneic CAR T cells, which are derived from healthy donors, are being studied to create universal CAR T cell products that can be used across multiple patients without the need for individualized manufacturing. Advancements in gene editing technologies, like CRISPR Cas9, can improve the precision and…
PR Newswire
06/11/2023

MAR Weekly Report_VIRBAC SA_October 30 to November 3 2023

Statement of transactions in own shares from 2023-10-30 to 2023-11-03BNP PARIBAS Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares *...
Nasdaq GlobeNewswire
06/11/2023

Surrealism in Scent Opus XV - King Blue joins Amouage's highly-acclaimed Library…

For his latest addition to the Collection,Renaud Salmon, Amouage's Chief Creative Officer, was inspired by his research into the Salon De Mayo, a gathering of influential artists which took place inHavanain 1967. Showcasing works by Magritte and Picasso, amongst others, the event broke barriers and succeeded in sharing the knowledge and practice of high art with an extensive audience. Salmon was especially struck by the surrealist art featured at the event – and specifically by...
PR Newswire
06/11/2023

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution…

New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data OXFORD, United Kingdom, Nov.06, 2023(GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer will present data from its Phase 2 Hepatitis B trials of VTP-300 at...
Nasdaq GlobeNewswire
06/11/2023

Multicenter US Study Reveals CP-GEP's Profound Impact on Stratifying Melanoma…

The patients were classified into two distinct categories: high risk and low risk for disease recurrence, offering critical insights into long-term prognosis. The patients were classified into two distinct categories: high risk and low risk for disease recurrence, offering critical insights into long-term prognosis. The study evaluated the 5-year recurrence-free survival (RFS), distant metastasis-free survival (DMFS), and melanoma-specific-free survival (MSS) for both CP-GEP high-risk and...
PR Newswire
06/11/2023

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 6 November 2023— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and...
Nasdaq GlobeNewswire
06/11/2023

King Faisal Specialist Hospital & Research Centre Successfully Concludes its…

As a Strategic Healthcare Partner, KFSH&RC showcased groundbreaking initiatives aimed at enhancing operational efficiency across crucial medical domains, encompassing the patient care journey, space research, genetic studies, state-of-the-art radiation therapy techniques, organ transplantation advancements (including a world-first fully robotic living donor transplant), capacity management, and the production of radiopharmaceuticals to attain self-sufficiency within the Kingdom...
Nasdaq GlobeNewswire
06/11/2023

T-knife Therapeutics Announces the Appointment of Simone Silva Steiner, Ph.D…

SAN FRANCISCO and BERLIN, Nov.06, 2023(GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing T cell receptor-based immunotherapies that deliver transformational benefits to cancer patients, today announced the appointment of Simone Silva Steiner, Ph.D., to the role of Chief Technical Operations Officer. “We are excited to welcome Simone to T-knife,” stated Thomas M. Soloway, Chief Executive Officer of T-knife. “Her impressive...
Nasdaq GlobeNewswire
06/11/2023

Biogen Appoints Monish Patolawala to its Board of Directors

Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformation Biogen Inc.(Nasdaq: BIIB) today announced the appointment of Monish Patolawala, currently President and Chief Financial Officer of 3M Company (“3M”), to the Company's Board of Directors (the “Board”), effective January 1, 2024. As an accomplished financial executive, Mr. Patolawala is qualified as an Audit Committee financial expert and may be asked to serve...
Nasdaq GlobeNewswire
06/11/2023

ADC Therapeutics to Participate in the Jefferies London Healthcare Conference

that 10:00 a.m. GMT.A live webcast of the fireside chat will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. A replay of the webcast will be available for approximately 30 days. About ADC Therapeutics ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the...
Nasdaq GlobeNewswire
06/11/2023

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress across the oncology pipeline with multiple late-stage trials initiated since third quarter startNew and expanded strategic collaborations reflect BioNTech's commitment to delivering transformational therapies for oncology and infectious...
Nasdaq GlobeNewswire
06/11/2023

Active Pharmaceutical Ingredients Market Set to Surge USD 363.68 Billion by 2032…

The API market was valued at 186.12 billion in 2020 and is expected to grow at a CAGR of 6.0%. Advancements in Active Pharmaceutical Ingredient (API) manufacturing, growth of biopharmaceutical sector, and increase in geriatric population are among key drivers of market growth. Rising prevalence of chronic diseases, such as cardiovascular diseases and cancer, is anticipated to boost the market growth. The API market was valued at 186.12 billion in 2020 and is expected to grow at a CAGR of 6...
PR Newswire
06/11/2023

Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland

Volition's Nu.Q® Vet Cancer Test is an accessible and affordable screening tool for dogs with increased risk of developing cancer, such as older dogs, certain breeds with higher cancer prevalence rates and those dogs with familial history. Volition's Nu.Q® Vet Cancer Test is an accessible and affordable screening tool for dogs with increased risk of developing cancer, such as older dogs, certain breeds with higher cancer prevalence rates and those dogs with familial history. DrTom Butera,...
PR Newswire
06/11/2023

Rising Digitalization to Revolutionize Healthcare Systems Boosting Pharmacy…

Robotic systems automate several physical tasks involved in pharmacy operations, such as dispensing medications, packaging prescriptions, and transporting medications throughout the pharmacy. This enables pharmacists to focus on more clinical tasks, such as patient counseling and medication management. Robotic systems automate several physical tasks involved in pharmacy operations, such as dispensing medications, packaging prescriptions, and transporting medications throughout the pharmacy...
PR Newswire
06/11/2023
Altri  Comunicati